These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. A clinical risk score for the prediction of very late stent thrombosis in drug eluting stent patients. Baran KW; Lasala JM; Cox DA; Mascioli SR; Song A; Deshpande MC; Jacoski MV; Dawkins KD; EuroIntervention; 2011 Mar; 6(8):949-54. PubMed ID: 21330242 [TBL] [Abstract][Full Text] [Related]
48. Very late stent thrombosis after dual antiplatelet therapy discontinuation in a patient with a history of acute stent thrombosis. Bhatt SH; Hauser TH Ann Pharmacother; 2008 May; 42(5):708-12. PubMed ID: 18381843 [TBL] [Abstract][Full Text] [Related]
51. Three years since the FDA advisory panel on drug-eluting stents: what have we learned about off-label use and stent thrombosis? Naidu SS J Invasive Cardiol; 2010 Jan; 22(1):20-1. PubMed ID: 20048394 [No Abstract] [Full Text] [Related]
52. Is implantation of drug-eluting stents a Faustian choice? Brener SJ J Invasive Cardiol; 2010 Oct; 22(10):465-6. PubMed ID: 20944184 [No Abstract] [Full Text] [Related]
53. Simultaneous subacute stent thrombosis after implantation of sirolimus-eluting stent and bare-metal stent. Kang WC; Moon CI; Ahn TH; Shin EK Int J Cardiol; 2008 Jul; 127(2):e89-92. PubMed ID: 17689731 [TBL] [Abstract][Full Text] [Related]
54. [Drug-eluting stents--for all, for some or for none?--Editorial]. Kocka V; Widimský P Vnitr Lek; 2007 Oct; 53(10):1033-4. PubMed ID: 18072425 [No Abstract] [Full Text] [Related]
55. Kounis hypersensitivity coronary syndrome is associated with presence of older thrombus in patients with late and very late drug-eluting stent thrombosis. Kounis NG; Kouni SA; Kouni SN; Kounis GN J Cardiol; 2012 Oct; 60(4):338. PubMed ID: 22727628 [No Abstract] [Full Text] [Related]
56. Late drug eluting stent thrombosis due to acemetacine: type III Kounis syndrome: Kounis syndrome due to acemetacine. Akyel A; Murat SN; Cay S; Kurtul A; Ocek AH; Cankurt T Int J Cardiol; 2012 Mar; 155(3):461-2. PubMed ID: 22222426 [No Abstract] [Full Text] [Related]
57. Management of clopidogrel hypersensitivity without drug interruption. Campbell KL; Cohn JR; Fischman DL; Walinsky P; Mallya R; Jaffrani W; Savage MP Am J Cardiol; 2011 Mar; 107(6):812-6. PubMed ID: 21247516 [TBL] [Abstract][Full Text] [Related]
58. The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy. Ayyanathan S; Hersh D; Coplan NL; Garratt K Prev Cardiol; 2009; 12(2):59-64. PubMed ID: 19476578 [TBL] [Abstract][Full Text] [Related]
59. The evidence base for platelet function testing in patients undergoing percutaneous coronary intervention. Price MJ Circ Cardiovasc Interv; 2010 Jun; 3(3):277-83; discussion 283. PubMed ID: 20551394 [No Abstract] [Full Text] [Related]
60. Minimizing the risks of anticoagulants and platelet inhibitors. Alexander KP; Peterson ED Circulation; 2010 May; 121(17):1960-70. PubMed ID: 20439812 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]